Clinical evaluation in adult human revealed the biosimilarity of recombinant Erythropoietin GBPD002 with Eprex®. acbr. 2023;7(4):459-474. Accessed September 17, 2026. https://fortunejournals.org/ojs/index.php/acbr/article/view/15029